Skip to content

Multicenter Imaging in Lead Extraction Study

Multicenter Imaging in Lead Extraction Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03772704
Acronym
MILES
Enrollment
200
Registered
2018-12-11
Start date
2018-12-13
Completion date
2020-11-04
Last updated
2020-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Complication of Cardiac Electronic Device

Brief summary

The primary objectives of this registry is to correlate the amount of fibrosis as documented on Electrocardiogram (ECG) gated Computed Tomography (CT) scans with ease of advancing sheaths over the leads through the SVC zone during lead extraction.

Detailed description

This is a multi-center, prospective, observational registry study which plans to enroll approximately 200 patients referred for Cardiac Implantable Electronic Device(CIED) lead extraction at one of the five study centers. The objective of this study is to determine whether a correlation exists between fibrosis detected on ECG gated cardiac CT and the ease of lead extraction as measured by need for extraction energy. All patients will be followed for 30 days post-lead extraction to assess vital status and re-hospitalizations via phone call

Interventions

None listed

Sponsors

Philips Healthcare
CollaboratorINDUSTRY
The Cleveland Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Referred for CIED (Cardiac Implantable Electronic Device) lead extraction with at least 1 lead with dwell time greater than one year * ≥ 18 years of age * Appropriate candidate for chest/cardiac CT with contrast and full lead analysis

Exclusion criteria

* Atrial fibrillation with uncontrolled rate

Design outcomes

Primary

MeasureTime frameDescription
Correlation of the presence and degree of fibrosis as determined by ECG gated cardiac CT with the presence and degree of fibrosis determined by ease of extraction sheath advancement30 daysThe presence and degree of fibrosis determined by the ease of extraction sheath advancement will be evaluated in three zones. Zone 1 will be the area before the Superior Vena Cava (SVC), Zone 2 in the SVC and Zone 3 after the SVC

Secondary

MeasureTime frameDescription
Major complications as defined by Heart Rhythm Society (HRS) 2017 consensus guidelines30 daysmajor complications
Minor complications as defined by HRS 2017 consensus guidelines30 daysminor complications
Mortality30 daysDeath assessed
Percentage of ECG gated CT scans that show fibrosis30 daysThe percentage of ECG gated CT scans will be determined by scans that show little to no SVC (Zone 2) fibrosis, show little to no Zone 1 fibrosis, show little to no Zone 3 fibrosis, cardiac perforation, extravascular lead location
Fluoroscopy time30 daysFluoroscopy duration of time
Pathological reports from extracted leads30 daysPathology reports from extracted leads if available
Hospitalizations directly related to the extraction of leads or procedure related30 daysNumber of hospitalizations related to the extraction of leads or procedure related within 30 days post procedure
Procedural outcomes30 daysOperator ease of extraction (grade 1-5)

Countries

Germany, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026